The largest database of trusted experimental protocols

6 protocols using pmirglo dual luciferase mirna target expression vector

1

miRNA Target Expression in HEK293T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Complementary oligonucleotide pairs comprising a portion of putative miRNA binding sites were synthesized (Thermo Fisher Scientific), annealed and cloned into the pmirGlo Dual Luciferase miRNA target expression vector (Promega Corporation, USA) between the NheI/NotI restriction sites of the multiple cloning site downstream of a luciferase gene.
For luciferase assays, HEK293T cells were seeded into 96-well cell culture pates. 24 h later, the cells were co-transfected with 200 ng of the pmirGlo Dual Luciferase miRNA target expression vector and miR-744-5p, microRNA inhibitor anti-miR-744-5p or non-targeting siRNA control (NT) at a final concentration of 50 nM using Lipofectamine 3000 (Thermo Fisher Scientific). Three days after transfection, cells were lysed with the Dual-Glo Reagent (Dual-Glo Luciferase Assay System; Promega Corporation, Mannheim, Germany) and luciferase activity was quantified on a SpectraMax M5e microplate reader (Molecular Devices, Sunnyvale, USA). After calculating the ratio of firefly luminescence to the luminescence from Renilla, the experimental well ratio was normalized to the ratio of the control wells.
+ Open protocol
+ Expand
2

miRNA 937-5p Binding Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Oligos specific to the wildtype (WT) PART1 miRNA 937-5p binding region and the mutated version of the sequence (MUT) are listed in Table S2. To make double stranded sequences for cloning, the oligos were admixed into oligo annealing buffer and heated to 90 °C for 3 min, followed by cooling to 37 °C for 15 min. The WT and MUT annealed oligos (ThermoFisher Scientific) were cloned into the multiple cloning site of the pmirGLO Dual-Luciferase miRNA Target Expression Vector (ThermoFisher Scientific, using SacI and XhoI restriction enzymes (New England Biolabs Ltd.). The confirmed vectors were co-transfected into HCC1806 cells with the pRLTK vector (Promega ThermoFisher Scientific), using TransIT-BRCA transfection reagent. 24 h later the mirVana miRNA negative control mimic or mimic-hsa-miR-937-5p (ThermoFisher Scientific) was transfected into the cells using TransIT-BRCA. The resulting firefly and renilla luciferase activity in the cells were measured 24 h later using the Dual-Glo® Luciferase Assay System (ThermoFisher Scientifc) with a SpectraMax® M3 Multi-Mode Microplate Reader (ThermoFisher Scientific). Binding of the mimic sequence to the luciferase reporter vector would inhibit production of luminescence.
+ Open protocol
+ Expand
3

Regulation of miR-10a-5p in NSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Chl1 3′-UTR-WT and 3′-UTR-MUT gene fragments were Role of miR-10a-5p in NSCs inserted into the pmirGlo ® Dual Luciferase miRNA target expression vector by GenePharma Co., Ltd. (Shanghai, China). For luciferase assays, HEK293T cells were co-transfected in 96-well plates with 200 ng of pmirGlo ® Dual Luciferase miRNA target expression vector and miR-10a-5p mimics or non-targeting siRNA control (NC) at a final concentration of 50 nM using Lipofectamine ® 2000 (Thermo Fisher Scientific) according to the manufacturer's instructions. Luciferase activities were measured with a Dual-Glo ® Luciferase Assay System (Promega, Madison, USA) after 24 and 48 h, and Renilla luciferase activity was normalized to Fluc activity.
+ Open protocol
+ Expand
4

Luciferase Assay for miRNA Target Validation

Check if the same lab product or an alternative is used in the 5 most similar protocols
CoV2‐miR‐O7a.2 site or CoV2‐miR‐O7a.2 with mutated seed region (Fig 4A) was cloned at the 3′UTR of luc‐2 in the pmirGLO Dual‐Luciferase miRNA Target expression vector (Promega E1330) according to manufacturer’s instruction. The sequence of oligonucleotides used for cloning is in Table EV1. 1 nM or 0.5 nM of CoV2‐miR‐O7a.2, or control mimics (Invitrogen) and 100 ng of pmirGLO Dual‐Luciferase miRNA Target expression vector with either CoV2‐miR‐O7a.2 site or CoV2‐miR‐O7a.2 with mutated seed region were transfected in A549‐ACE2 using Lipofectamine 3000 (Thermo Fischer Scientific) following the manufacturer’s instructions. 24 h post‐transfection, cells were lysed with passive lysis buffer (Promega) and firefly and Renilla luciferase activities were detected using Dual‐Glo Luciferase Assay System (Promega). Data are normalized by calculation of the ratio of luminescence from reporter firefly to internal control Renilla luciferase.
+ Open protocol
+ Expand
5

Validating miRNA-mRNA Interactions with Luciferase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
For analysis of predicted miR-125b binding sites, synthesize complementary 50–60 mer DNA oligonucleotides consisting of the 3′-UTR sequence of candidate target genes that were cloned into pmirGLO Dual-Luciferase miRNA Target Expression Vector (Invitrogen, USA). The blank vector was used as a negative control. The sequences of oligonucleotide pairs that contain the desired miRNA target region are shown (Supplementary Table S8). The Design oligonucleotides are cloned into pmirGLO vectors according to the manufacturer’s instructions. MGC-803 and SGC-7901 cells maintained in the 24-well plates were transfected with 0.4 µg of the pMIR-REPORT Luciferase plasmids (Wild type and mutant vectors) and miRNA (miR-125b/mimic control) using the Lipofectamine 3000 (Invitrogen, USA). The relative luminescence was measured using the Dual-Luciferase Reporter Assay Kit (Promega, USA) 24 h post-transfection.
+ Open protocol
+ Expand
6

Validating miR-590-3p Binding to CASC9

Check if the same lab product or an alternative is used in the 5 most similar protocols
The CASC9 fragments containing the predicted miR-590-3p binding sites were separately amplified via RT-qPCR analysis and cloned into a pmirGLO dual luciferase miRNA target expression vector (Invitrogen; Thermo Fisher Scientific, Inc.) to create a wild-type CASC9 reporter vector. Subsequently, the putative mutant miR-590-3p binding sites were constructed in CASC9 by altering the sequences and replacing them to form a CASC9-mutated-type. The miRNAs (miR-590-3p mimics or miR-NC) and recombinant plasmids were co-transfected into 293T cells (American Type Culture Collection), using Lipofectamine® 3000 (Invitrogen; Thermo Fisher Scientific, Inc.). Following incubation for 48 h at 37°C, luciferase activities were detected using a dual luciferase reporter gene assay system (Promega Corporation). Firefly luciferase activity was normalized to Renilla luciferase activity.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!